Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 3
1 (33.3%)A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome
Phase 3
Completed
- Conditions
- Menopausal Syndrome
- Interventions
- Drug: UNCNTDrug: MELSMON
- First Posted Date
- 2013-08-29
- Last Posted Date
- 2014-05-08
- Lead Sponsor
- Unimed Pharmaceuticals
- Target Recruit Count
- 104
- Registration Number
- NCT01931748
- Locations
- 🇰🇷
Inha Univ.Hospital,, Incheon, Korea, Republic of
🇰🇷Korea University Medical center Anam Hospital, Seoul, Korea, Republic of
Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.
- First Posted Date
- 2013-03-11
- Last Posted Date
- 2013-08-22
- Lead Sponsor
- Unimed Pharmaceuticals
- Target Recruit Count
- 42
- Registration Number
- NCT01808300
A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Unimed Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT00002444
- Locations
- 🇺🇸
New York Hosp / Cornell Med Ctr, New York, New York, United States
News
No news found